These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23024264)

  • 1. Preconditioning of stem cells by oxytocin to improve their therapeutic potential.
    Noiseux N; Borie M; Desnoyers A; Menaouar A; Stevens LM; Mansour S; Danalache BA; Roy DC; Jankowski M; Gutkowska J
    Endocrinology; 2012 Nov; 153(11):5361-72. PubMed ID: 23024264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro.
    Wang F; Zhou H; Du Z; Chen X; Zhu F; Wang Z; Zhang Y; Lin L; Qian M; Zhang X; Li X; Hao A
    Eur J Pharmacol; 2015 Feb; 748():157-65. PubMed ID: 25281200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis.
    Lee JH; Yoon YM; Lee SH
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion.
    Gonzalez-Reyes A; Menaouar A; Yip D; Danalache B; Plante E; Noiseux N; Gutkowska J; Jankowski M
    Mol Cell Endocrinol; 2015 Sep; 412():170-81. PubMed ID: 25963797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro.
    Zhou H; Li D; Shi C; Xin T; Yang J; Zhou Y; Hu S; Tian F; Wang J; Chen Y
    Sci Rep; 2015 Aug; 5():12898. PubMed ID: 26250571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.
    Chen J; Baydoun AR; Xu R; Deng L; Liu X; Zhu W; Shi L; Cong X; Hu S; Chen X
    Stem Cells; 2008 Jan; 26(1):135-45. PubMed ID: 17932426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.
    Bader AM; Klose K; Bieback K; Korinth D; Schneider M; Seifert M; Choi YH; Kurtz A; Falk V; Stamm C
    PLoS One; 2015; 10(9):e0138477. PubMed ID: 26380983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulfide augments the proliferation and survival of human induced pluripotent stem cell-derived mesenchymal stromal cells through inhibition of BKCa.
    Zhao Y; Wei H; Kong G; Shim W; Zhang G
    Cytotherapy; 2013 Nov; 15(11):1395-405. PubMed ID: 23992829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic Effect of Oxytocin and Tacrolimus Combination on Adipose Tissue - Derived Mesenchymal Stem Cells: Antagonistic effect of oxytocin and tacrolimus.
    Sir G; Goker Bagca B; Yigitturk G; Cavusoglu T; Biray Avci C; Gunduz C; Uyanikgil Y
    Biomed Pharmacother; 2018 Jan; 97():1173-1181. PubMed ID: 29136956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential.
    Zhang Q; Liu S; Li T; Yuan L; Liu H; Wang X; Wang F; Wang S; Hao A; Liu D; Wang Z
    Oncotarget; 2016 Sep; 7(36):58089-58104. PubMed ID: 27517324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor is an obligatory intermediate for oxytocin-induced cyclooxygenase 2 expression and prostaglandin F2 alpha production in bovine endometrial epithelial cells.
    Krishnaswamy N; Lacroix-Pepin N; Chapdelaine P; Taniguchi H; Kauffenstein G; Chakravarti A; Danyod G; Fortier MA
    Endocrinology; 2010 Mar; 151(3):1367-74. PubMed ID: 20080869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells.
    Wang JA; Chen TL; Jiang J; Shi H; Gui C; Luo RH; Xie XJ; Xiang MX; Zhang X
    Acta Pharmacol Sin; 2008 Jan; 29(1):74-82. PubMed ID: 18158868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.
    Sun X; Fang B; Zhao X; Zhang G; Ma H
    PLoS One; 2014; 9(3):e90667. PubMed ID: 24599264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin revisited: its role in cardiovascular regulation.
    Gutkowska J; Jankowski M
    J Neuroendocrinol; 2012 Apr; 24(4):599-608. PubMed ID: 21981277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of functional oxytocin receptors in human breast Hs578T cells and their up-regulation through a protein kinase C-dependent pathway.
    Copland JA; Jeng YJ; Strakova Z; Ives KL; Hellmich MR; Soloff MS
    Endocrinology; 1999 May; 140(5):2258-67. PubMed ID: 10218979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.